Three takeaways from the revised forecast, according to a June 30 press release:
- Net revenues are estimated to be about $13.23 billion to $13.37 billion, representing decreases of 1.4 percent to 2.4 percent as compared to the original 2022 forecasted net revenues.
- Adjusted EBITDA, net of NCI, is estimated to be about $1.63 billion to $1.71 billion, a decrease of 10.7 percent to 11.2 percent of the original forecast.
- Adjusted earnings per share-diluted are estimated to be $9.60 per share to $10.40 per share, a decrease of 19.3 percent as compared to the original forecast.
UHS said that the continued uncertainties related to the COVID-19 pandemic, as well as the healthcare staffing shortage and its unfavorable impact on labor costs and behavioral health patient volumes, contributed to the revision.
